Skip to main content
. 2019 Nov 18;5(2):175–182. doi: 10.1001/jamacardio.2019.4965

Figure 2. Sensitivity Analysis of Patients Receiving Varying Heart Failure Therapies.

Figure 2.

A, Fully adjusted survival curves accounting for time variation in patients’ medications throughout the follow-up period. B, Forest plot for fully adjusted Cox proportional hazards regression model. ACEi indicates angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blockers; BB, β-blockers; HR, hazard ratio; INTERMACS, Interagency Registry for Mechanically Assisted Circulatory Support; LVAD, left ventricular assist device; MRA, mineralocorticoid antagonists; NHB, neurohormonal blockade.